At the high dose of immunization (5×106 cells per mouse), both CMT.TAP1/B7.1-immunized and CMT.B7.1/p-immunized mice were well protected from live tumor attack (Fig. 2C left-panel). The gene discussed is CD80; the disease is neoplasm.